Table 4. Postoperative course and distribution of complications in 290 patients undergoing CABG.

	without complication	with complication	p-Value
	(n=254)	(n=36)
Reoperation	7 (2.8%)	3 (8.6%)	.108
ICU stay (days)	0.9 ± 0.2	2 ± 1.9	<0.001
ICU >2 days (%)	0	12 (33.3%)	<0.001
ICU readmission (%)	0	4 (11.1%)	<0.001
ICU stay total (days)	0.9 ± 0.2	2.8 ± 4.3	<0.001
Intubation time (days)	0.5 ± 0.1	1.1 ± 0.9	<0.001
Hosp duration (days)	7.1 ± 3.2	12.1 ± 9.1	<0.001
Mortality (%)	0	1 (2.8%)	.124
Stroke (%)	0	4 (11.1%)	<0.001
Post-operative creatinin (umol/L)	95.9 ± 39.9	177.4 ± 121.8	<0.001
New renal insufficiency (%)	0	8 (22.9%)	<0.001
New Dialysis (%)	0	1 (2.9%)	.121
Post-operative MI (%)	0	6 (16.7%)	<0.001
Resuscitation (%)	0	1 (2.8%)	.124
Atrial fibrillation (%)	44 (17.4%)	2 (6.3%)	.129
Need for blood products (%)	119 (47.6%)	20 (64.5%)	.088
Need for vasopressors at 6h (%)	24 (9.4%)	12 (33.3%)	<0.001
Need for vasopressors at 24h (%)	0	17 (47.2%)	<0.001
Adrenaline_6h (µg)	440 ± 211	630 ± 832	0.522
Dobutrex_6h (µg)	31.5 ± 22.1	50.1 ± 11.3	.061
Noradrenaline_6h (µg)	459 ± 245	1433 ± 2303	.518
Adrenaline_24h (µg)	92 ± 156	621 ± 1085	.354
Dobutrex_24h (µg)	71.4 ± 49.4	161.3 ± 158.9	.021
Noradrenaline_24h (µg)	266 ± 452	172 ± 203	.943

ICU, intensive care unit